A Systematic Review of the Effects of Lamotrigine on Cognitive Function and Quality of Life

Epilepsy and Behavior

Volumn 2, Issue 2, 2001, Pages 85-91

  Aldenkamp, A P ^a,b   Baker, G ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Lamotrigine; antiepileptic drugs; cognition; mood; behavior; epilepsy; quality of life

Indexed keywords

EID: 0002689598     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2001.0168     Document Type: Review

References (43)

1. Rowan A J. Reflections on the treatment of seizures in the elderly population. Neurology. 51:1998;S28-33.
2. Willmore L J. Management of epilepsy in the elderly. Epilepsia. 37:1996;S23-33.
3. Feely M. Fortnightly review: drug treatment of epilepsy. Br Med J. 318:1999;106-109.
4. Buchanan N. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure. 4:1995;233-236.
5. Aldenkamp A P, Mulder O G, Overweg J. Cognitive effects of lamotrigine as first line add-on in patients with localized related (partial) epilepsy. J Epilepsy. 10:1997;117-121.
6. Banks G K, Beran R G. Neuropsychological assessment in lamotrigine treated epileptic patients. Clin Exp Neurol. 28:1991;230-237.
7. Tekin S, Aykut-Bingol C, Tanridag T, Aktan S. Antiglutamatergic therapy in Alzheimer's disease: effects of lamotrigine. Short communication. J Neural Transmission (Budapest). 105:1998;295-303.
8. Cohen A F, Ashby L, Crowley D. Lamotrigine (BW430C), a potential anticonvulsant: effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol. 20:1985;619-629.
9. Martin R, Kuzniecky R, Ho S. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology. 52:1999;321-327.
10. Hamilton M J, Cohen A F, Yuen A W. Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage. Epilepsia. 34:1993;166-173.
11. Meador K J, Loring D W, Ray P G. Differential effects of carbamazepine and lamotrigine. Neurology. 54:2000;A84.
12. Aldenkamp, A, P, Arends, J, Bootsma, H, P, A randomised double-blind parallel group study comparing cognitive effects of lamotrigine with placebo and valproate in healthy volunteers. Submitted to the 24th International Epilepsy Congress, 2001.
13. Vermeulen J, Aldenkamp A P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res. 22:1995;65-95.
14. Brodie M J, Read C L, Gillham R, Sweet R M, Kane K. Lack of neuropsychological effects of lamotrigine compared to carbamazepine as monotherapy. Epilepsia. 40:1999;94.
15. Smith D, Baker G, Davies G, Dewey M, Chadwick D W. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 34:1993;312-322.
16. Ettinger A B, Weisbrot D M, Saracco J. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia. 39:1998;874-877.
17. Earl N, McKee J R, Sunder T R. Lamotrigine adjunctive therapy in patients with refractory epilepsy and mental retardation. Epilepsia. 41:2000;72.
18. Aarts J H, Binnie C D, Smit A M, Wilkins A J. Selective cognitive impairment during focal and generalized epileptiform EEG activity. Brain. 107:1984;293-308.
19. Aldenkamp A P, Overweg J, Gutter T. Effect of epilepsy, seizures and epileptiform EEG discharges on cognitive function. Acta Neurol Scand. 93:1996;253-259.
20. Binnie C D. Cognitive impairment: is it inevitable? Seizure. 3:1994;17-21.
21. Binnie C D, van Emde B W, Kasteleijn-Nolste-Trenite D G. Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia. 27:1986;248-254.
22. Marciani M G, Spanedda F, Bassetti M A. Effect of lamotrigine on EEG paroxysmal abnormalities and background activity: a computerized analysis. Br J Clin Pharmacol. 42:1996;621-627.
23. Marciani M G, Stanzione P, Mattia D. Lamotrigine add-on therapy in focal epilepsy: electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol. 21:1998;41-47.
24. Mervaala E, Koivista K, Hanninen T. Electrophysiological and neuropsychological profiles of lamotrigine in young and age-associated memory impairment (AAMI) subjects. Neurology. 45:1995;A259.
25. + channels in rat hippocampal neurones. Pfluegers Arch. 430:1995;437-446.
26. Leach M J, Marden C M, Miller A A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia. 27:1986;490-497.
27. Wang S J, Huang C C, Hsu K S, Tsai J J, Gean P W. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. NeuroReport. 7:1996;3037-3040.
28. Leach M J, Baxter M G, Critchley M A. Neurochemical and behavioral aspects of lamotrigine. Epilepsia. 32:1991;S4-8.
29. Smith S E, Meldrum B S. Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke. 26:1995;117-121.
30. Bliss T V, Collingridge G L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
31. Xiong Z Q, Stringer J L. Effects of felbamate, gabapentin and lamotrigine on seizure parameters and excitability in the rat hippocampus. Epilepsy Res. 27:1997;187-194.
32. Otsuki K, Morimoto K, Sato K, Yamada N, Kuroda S. Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats. Epilepsy Res. 31:1998;101-112.
33. Wiard R P, Dickerson M C, Beek O, Norton R, Cooper B R. Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke. 26:1995;466-472.
34. Brown S W, Tomlinson L L. Anticonvulsant side-effects: a self report questionnaire for use in community surveys. Br J Clin Pract. 18:1982;147-149.
35. Gillham R, Baker G, Thompson P. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res. 24:1996;47-55.
36. Steiner T J, Dellaportas C I, Findley L J. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia. 40:1999;601-607.
37. Bryant-Comstock L, Kane K, Moorat A. Quality of life improvement in patients treated with lamotrigine compared with valproate. Epilepsia. 40:1990;98.
38. Jacoby A, Baker G, Bryant-Comstock L, Phillips S, Bamford C. Lamotrigine add-on therapy is associated with improvement in mood in patients with severe epilepsy. Epilepsia. 37:1996;202.
39. Uvebrant P, Bauziene R. Intractable epilepsy in children: the efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics. 25:1994;284-289.
40. Schlumberger E, Chavez F, Palacios L. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia. 35:1994;359-367.
41. Besag F MC, Wallace S J, Hosking G. Lamotrigine for the treatment of epilepsy in childhood. J Pediatr. 127:1995;991-997.
42. Ketter T A, Post R M, Theodore W H. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology. 53:1999;S53-67.
43. Edwards K, Kalogjera-Sackellares D, Sackellares C. Lamotrigine monotherapy improves mood in epilepsy: a randomized double-blind comparison with valproate. Epilepsia. 41:2000;104.